Markers of progression and invasion in short term follow up of untreated breast cancer patients.

作者: Zaki Abu Rabi , Nataša Todorović-Raković , Tijana Vujasinović , Jelena Milovanović , Dragica Nikolić-Vukosavljević

DOI: 10.3233/CBM-150516

关键词: Plasminogen activator inhibitor-1Plasminogen activatorOncologyBiologyMetastasisVascular endothelial growth factorAngiogenesisBreast cancerCancerMMP2PathologyInternal medicine

摘要: BACKGROUND: Cancer progression and metastasis are complex processes, dependent of molecules involved in inflammation, degradation invasion. These can be used as prognostic indicators to single out patients with higher risk recurrence. Interleukin-8 (IL-8) has a role urokinase plasminogen activator (uPA), inhibitor type-1 (PAI-1) matrix metalloproteinase-2, -9 have decisive part the process invasion, while vascular endothelial growth factor (VEGF) is consequential for angiogenesis. OBJECTIVES: Aim our study determine relations between IL-8, uPA, PAI-1, MMP-2, -9, VEGF their significance terms recurrence free survival. METHODS: This included 91 untreated lymph node negative (N0) primary breast cancer. RESULTS: Patients levels uPA (p = 0.05), PAI-1 (0.05), MMP2 0.05) IL-8 0.02) poor prognosis. Positive correlations were found ER – PR, MMP9, MMP9 VEGF. Negative CONCLUSIONS: Higher concentrations MMP2, VEGF, confirmed aggressive phenotype prognosis different subgroups.

参考文章(47)
Tomasz Motyl, Agnieszka Jezierska, Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Medical Science Monitor. ,vol. 15, ,(2009)
A. Prechtl, N. Harbeck, C. Thomssen, C. Meisner, M. Braun, M. Untch, M. Wieland, B. Lisboa, T. Cufer, H. Graeff, K. Selbmann, M. Schmitt, F. JÄnicke, Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer. International Journal of Biological Markers. ,vol. 15, pp. 73- 78 ,(2000) , 10.1177/172460080001500114
Michelle L Varney, Rakesh K Singh, VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner. American Journal of Cancer Research. ,vol. 5, pp. 616- 628 ,(2015)
Enrique A. Mesri, Celina G. Kleer, Sofia D. Merajver, Diane M. Robins, Quintin Pan, Carlos Bias, Kristen M. Bottema, Jennifer Irani, George J. Brewer, Robert D. Dick, Kenneth L. Van Golen, Magda De Carvalho, Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Research. ,vol. 62, pp. 4854- 4859 ,(2002)
Ulrich Fink, Jürgen D. Roder, Jörg R. Siewert, Karen Becker, Manfred Schmitt, Hjalmar Nekarda, Holger Vogelsang, Kurt Ulm, Andrea Wenninger, Prognostic Impact of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Completely Resected Gastric Cancer Cancer Research. ,vol. 54, pp. 2900- 2907 ,(1994)
María Fernanda García, Salomé González-Reyes, Luis Ovidio González, Sara Junquera, Nana Berdize, José Manuel Del Casar, María Medina, Francisco José Vizoso, Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer International Journal of Experimental Pathology. ,vol. 91, pp. 324- 334 ,(2010) , 10.1111/J.1365-2613.2010.00709.X
Steingrimur Stefansson, Daniel A. Lawrence, The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. ,vol. 383, pp. 441- 443 ,(1996) , 10.1038/383441A0
He-cheng Li, Dao-cheng Cao, Yi Liu, Yi-feng Hou, Jiong Wu, Jin-song Lu, Gen-hong Di, Gang Liu, Fang-ming Li, Zhou-luo Ou, Cui Jie, Zhen-zhou Shen, Zhi-ming Shao, Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Research and Treatment. ,vol. 88, pp. 75- 85 ,(2004) , 10.1007/S10549-004-1200-8
W. Kuhn, L. Pache, B. Schmalfeldt, P. Dettmar, M. Schmitt, F. Jänicke, H. Graeff, Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy Gynecologic Oncology. ,vol. 55, pp. 401- 409 ,(1994) , 10.1006/GYNO.1994.1313